caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1699099192

Andrea LingM.D.

Pulmonary DiseaseSanta Cruz, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Andrea Ling's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 25 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
DIGNITY HEALTH169656
Evan Sirc
Nuclear Medicine · Santa Cruz, CA
101456
Nicholas Astromoff
Diagnostic Radiology · Santa Cruz, CA
94495
REA, RANDALL67295
SCHMETZ, MARK63176
Roy Martinez
Diagnostic Radiology · Santa Cruz, CA
60210
Annette Rasi
Diagnostic Radiology · Salinas, CA
3885
Jon Keller
Pathology · Palo Alto, CA
36208
Jennifer Lin
Diagnostic Radiology · Santa Cruz, CA
3499
Neil Sawhney
Interventional Cardiology · Santa Cruz, CA
25192
Robert Potts
Family Practice · Soquel, CA
2383
Victor Ochoa
Cardiology · Sacramento, CA
2240
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
329
Unique beneficiaries
—
Total services
554
Distinct HCPCS
10
Medicare payment
$68K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 901 Pulmonary Disease providers in CA — below median (cohort median 927).
PRESCRIBING · PART D · 2024
Total Rx claims
591
Beneficiaries
—
Total drug cost
$571K
Distinct drugs
19
Brand share
70.9%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter104 claims
Albuterol Sulfate69 claims
Fluticasone/Vilanterol59 claims
Prednisone46 claims
Montelukast Sodium41 claims
QUALITY · MIPS · 2024
Final MIPS score
99.6
Quality
86.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.04%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.